Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exela Pharma Sciences is a US-based, fully integrated specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary sterile injectable products, primarily for hospital use. Its offerings include both its own branded/generic injectables and contract development and manufacturing (CDMO) services. Exela is known for rapidly addressing critical US drug shortages via its FDA-registered cGMP facilities and has launched multiple first-to-market generic sterile injectables, saving patients millions of dollars. The company has received recognition for manufacturing excellence and supply chain reliability, and has played a significant role in domestic pharmaceutical manufacturing resilience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exela Pharmaceuticals.